Cannabis has been considered an illegal substance globally since the creation of the Single Convention on Narcotic Drugs (The Convention) in 1961. The Convention is an international treaty which outlines the prohibition of certain drugs and is in place to prevent their production and supply, unless they are being produced for scientific or certain medicinal purposes. This was an attempt by the UN to try and reduce the supply of drugs entering through illegal channels and being sold on the black market. Under The Convention, cannabis had the same restrictions placed upon its cultivation and distribution as opioids.

All the countries we will provide an overview on are signatories to The Convention and in total there are 186 parties involved in the treaty1. Over the past two decades, many of the positive effects of, or more specifically, certain types of cannabis, have come to light. Many countries across the globe are now taking steps to open up legal avenues for the production, sale and consumption of cannabis, reflecting scientific research which shows that it has the ability to help people with a wide range of medical issues from Cancer to Alzheimer's and sociological evidence showing that the criminalization of cannabis is of questionable benefit. With the evidence in favor of legalization seemingly mounting, cannabis is expected to be an industry worth USD$66.3 billion globally by the end of 2025.2

In this piece we explore the current regulatory regimes enforced in a selection of jurisdictions and take a look at what the future holds for the development of these regulatory regimes worldwide.

Footnotes

1. Treaties.un.org. (2020). UNTC. [online] Available at: https://treaties.un.org/Pages/ViewDetails.aspx?src=TREATY&mtdsg_no=VI-18&chapter=6&clang=_en [Accessed 10 Feb. 2020].

2. Grand View Research, 2019 Legal Marijuana Market Worth $66.3 Billion By 2025 | CAGR: 23.9% https://www.grandviewresearch.com/press-release/global-legal-marijuana-market 


About Norton Rose Fulbright Canada LLP

Norton Rose Fulbright is a global law firm. We provide the world's preeminent corporations and financial institutions with a full business law service. We have 3800 lawyers and other legal staff based in more than 50 cities across Europe, the United States, Canada, Latin America, Asia, Australia, Africa, the Middle East and Central Asia.

Recognized for our industry focus, we are strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare.

Wherever we are, we operate in accordance with our global business principles of quality, unity and integrity. We aim to provide the highest possible standard of legal service in each of our offices and to maintain that level of quality at every point of contact.

For more information about Norton Rose Fulbright, see nortonrosefulbright.com/legal-notices.

Law around the world
nortonrosefulbright.com

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.